Identification of Chinese Herbal Compounds with Potential as JAK3 Inhibitors

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Janus kinases (JAKs) are critical in immune signaling, with JAK3 being a key target for inflammatory disease treatment.
• Existing JAK3 inhibitors face challenges like drug resistance and side effects, necessitating the search for novel candidates.

Purpose of the Study:

• To virtually screen Chinese herbal compounds for potential JAK3 inhibition.
• To identify and validate natural compounds with direct inhibitory activity against JAK3 kinase.

Main Methods:

• Virtual screening of ~36,000 compounds using AutoDock Vina and filtering with Lipinski's Rules and ADME/T predictions.
• In vitro validation using enzymatic assays, western blot, and cell-based transactivity assays.
• Molecular dynamics simulations to analyze protein-ligand interactions and binding modes.

Main Results:

• Cryptotanshinone, Icaritin, and Indirubin demonstrated significant in vitro inhibitory activity against JAK3 kinase.
• Detailed binding models revealed key amino acid interactions within the JAK3 ATP-binding domain.
• Three natural compounds were identified as potent JAK3 inhibitors.

Conclusions:

• Discovery of Cryptotanshinone, Icaritin, and Indirubin as promising natural inhibitors of JAK3.
• These compounds offer new therapeutic possibilities for JAK3-targeted diseases.
• The study provides insights into JAK3-ligand interactions for future drug development.